7DING L,ZHOU X,YANG L,et al.Liquid chromatography/electrospray ionization mass spectrometry method for the determination of the active metabolite M-1 of suplatast tosilate in human plasma[J].Biomed Chromatogr,2007,21(12):1297-1302.
8MURAKAMI T,YAMANAKA K,TOKIME K,et al.Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5[J].Br J Dermatol,2006,155(1):27-32.
9HOSHINO M,FUJITA Y,SAJI J,et al.Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma[J].Allergy,2005,60(11):1394-1400.
10TAMAOKI J,KONDO M,SAKAI N,et al.Effect of suplatast tosilate,a Th2 cytokine inhibitor,on steroid-dependent asthma:a double-blind randomised study.Tokyo Joshi-Idai Asthma Research Group[J].Lancet,2000,356(9226):273-278.
